Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors
Clinical trial NCT00110357 · COMPLETED
Trial details
- NCT number
- NCT00110357
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2008-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.